Mirikizumab-Mrkz 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 100 mg

Reference Brands: Omvoh (USA)

Category: Immune Disorder

Mirikizumab-Mrkz is a Immune Disorder product available as Injection in strengths 100 mg. It corresponds to the reference brand Omvoh (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Mirikizumab‑MRKZ, marketed under the brand name Omvoh, is a monoclonal antibody approved for the treatment of moderately to severely active ulcerative colitis in adults. It works by selectively binding to interleukin-23 (IL-23), a cytokine involved in immune-mediated inflammation, and blocking its activity. This targeted mechanism helps reduce inflammation in the gastrointestinal tract and supports mucosal healing, offering a precision-based approach to managing ulcerative colitis.

Administered via subcutaneous injection, Omvoh is designed for patients who have not responded adequately to conventional therapies. The therapy provides a focused immunomodulatory effect while minimizing broader systemic immunosuppression. Patients receiving Omvoh should be monitored for potential adverse events, which most commonly include upper respiratory tract infections, headache, rash, and injection-site reactions. Its development and production are overseen by Eli Lilly and Company in clinical-grade facilities to ensure high-quality manufacturing and safety standards.

Omvoh represents an important therapeutic option in the management of ulcerative colitis, providing targeted disease control and improving patient quality of life through a novel mechanism of action.